Enhancing The Blood-brain Barrier Efflux Of ?-amyloid: A Novel Approach For The Treatment Of Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$291,274.00
Summary
Alzheimer’s disease (AD) is the leading cause of dementia and is associated with the accumulation of a toxic protein in the brain. This project will investigate whether enhancing the removal of this toxic protein from the brain (by shuttling it into the blood) will restore the memory deficit associated with AD. The outcomes of this project have the potential to lead to novel strategies for the treatment of this debilitating disorder.
Low Strength Silver Fluoride Solutions As Clinically Effective Bacteriostatic And Cariostatic Agents
Funder
National Health and Medical Research Council
Funding Amount
$147,800.00
Summary
Scientific evidence indicates that low concentrations of silver are effective in countering bacteria involved in dental decay, and that solutions of silver fluoride are effective in stopping progression of dental decay. This study aims to determine the effectiveness of low strength silver fluoride solutions in the clinical management of dental decay in children. Such solutions may provide a simplified technique for controlling dental decay in populations which lack traditional resources
INVESTIGATIONS ON THE REGULATION OF INTERVERTEBRAL DISC CELL MATRIX METALLOPROTEINASES
Funder
National Health and Medical Research Council
Funding Amount
$331,320.00
Summary
Degeneration of the intervertebral disc is a painful disabling condition with major socioeconomic consequences. Medical problems associated with disc degeneration and back-pain, of sufficient severity to warrant consultation with a physician, are experienced by 90% of the population some time during their lives. In man, back pain increases in incidence in the third and fourth decades of life, peaks in the fifties and declines thereafter. Changes in population demographics indicate this problem w ....Degeneration of the intervertebral disc is a painful disabling condition with major socioeconomic consequences. Medical problems associated with disc degeneration and back-pain, of sufficient severity to warrant consultation with a physician, are experienced by 90% of the population some time during their lives. In man, back pain increases in incidence in the third and fourth decades of life, peaks in the fifties and declines thereafter. Changes in population demographics indicate this problem will increase in severity over the next few decades. American Bureau of Census data indicate that between 1990 to 2010 the number of people >45 years will increase from 82 to 124 million, the number of elderly in emerging countries will also increase between 200 to 400% in the next 30 years. In the United States, back-pain is the second most common reason that people visit a physician and medical conditions related to back-pain account for more hospitalisations than any other musculoskeletal disorder. Despite its high incidence, associated problems of incapacity and economic implications, costed at $100 million per annum in Australia in 1992, and US$100 billion globally in 1999-2000 (Dorland Data Networks, PA, USA) the causes of low back-pain are still poorly understood. Disc disease is responsible for 23-40% of all cases of low back-pain. The management of discogenic low back-pain is currently empirical, directed either toward life-style changes to minimise symptomatology or to surgical resection or spinal arthrodesis to restrict articulation. Based on our recent findings and those of colleagues over the last 16 years, it is our strong conviction that it should be possible with a better understanding of disease mechanisms and with the use of modern technologies to inhibit, reverse or ideally prevent disc degeneration. Without such basic research there will be no scientific foundation upon which prospective therapies may be based.Read moreRead less
Low back pain is a major global health problem and the leading cause of disability worldwide . This project will trial a new treatment for back pain that is specifically aimed at risk factors for developing ongoing back problems. Previously shown to be successful in patients suffering persistent back problems, this promising new treatment will be trialled in patients soon after they develop lower back pain as a preventative approach.
SUcceSS: SUrgery For Spinal Stenosis - A Randomised Placebo-controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$2,303,245.00
Summary
This will be the first placebo-controlled randomised trial of surgery for lumbar spinal stenosis and aims to determine the efficacy and safety of this intervention in decreasing pain and improving disability in this population. The cost-effectiveness of surgery for lumbar spinal stenosis will also be determined.
Derivation, Transportability, And Usefulness Of Clinical Prediction Rules For Low Back Pain
Funder
National Health and Medical Research Council
Funding Amount
$333,515.00
Summary
Low back pain (LBP) is a very common and expensive health condition worldwide. To help clinicians manage LBP and other health conditions, clinical prediction rules can be used to identify patients at risk of prolonged suffering and prescribe appropriate treatments. This research program will determine the best methods to develop these rules and measure the effect they have on the burden of LBP. The findings will also contribute to improving the management of many other health conditions.